Physiologic and Molecular Responses of the Heart to Chronic Exercise

Muscle: Fundamental Biology and Mechanisms of Disease

Volumn 1-2, Issue , 2012, Pages 323-330

  Levine, Benjamin ^a   Buttrick, Peter ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882892957     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381510-1.00024-7     Document Type: Chapter

References (72)

1. Hoppeler H, Weibel ER. Limits for oxygen and substrate transport in mammals. J Exp Biol 1998, 201:1051-1064.
2. Baggish A.L., Wood M.J. Athlete's heart and cardiovascular care of the athlete: scientific and clinical update. Circulation 2010, 123:2723-2735.
3. Mills J.D., Moore G.E., Thompson P.D. The athlete's heart. Clin Sports Med 1997, 16:725-737.
4. Pavlik G., Major Z., Varga-Pinter B., Jeserich M., Kneffel Z. The athlete's heart part I (Review). Acta Physiol Hung 2010, 97:337-353.
5. Weeks K.L., McMullen J.R. The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes?. Physiology (Bethesda) 2010, 26:97-105.
6. Saltin B., Blomqvist G., Mitchell J.H., Johnson R.L., Wildenthal K., Chapman C.B. Response to exercise after bed rest and after training. Circulation 1968, 38:VII1-78.
7. Cooper G.T. Load and length regulation of cardiac energetics. Annu Rev Physiol 1990, 52:505-522.
8. Kent R.L., Mann D.L., Cooper G.t. Signals for cardiac muscle hypertrophy in hypertension. J Cardiovasc Pharmacol 1991, 17(Suppl 2):S7-S13.
9. Korecky B., Masika M. Direct effect of increased hemodynamic load on cardiac mass. Circ Res 1991, 68:1174-1178.
10. Imamura T., McDermott P.J., Kent R.L., Nagatsu M., Cooper G.T., Carabello B.A. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload. Circ Res 1994, 75:418-425.
11. Rozich J.D., Barnes M.A., Schmid P.G., Zile M.R., McDermott P.J., Cooper G.T. Load effects on gene expression during cardiac hypertrophy. J Mol Cell Cardiol 1995, 27:485-499.
12. Cooper G.T., Kent R.L., Mann D.L. Load induction of cardiac hypertrophy. J Mol Cell Cardiol 1989, 21(Suppl 5):11-30.
13. Zile M.R., Tomita M., Ishihara K., Nakano K., Lindroth J., Spinale F., et al. Changes in diastolic function during development and correction of chronic LV volume overload produced by mitral regurgitation. Circulation 1993, 87:1378-1388.
14. Cooper G.T. Cardiocyte adaptation to chronically altered load. Annu Rev Physiol 1987, 49:501-518.
15. Urabe Y., Mann D.L., Kent R.L., Nakano K., Tomanek R.J., Carabello B.A., et al. Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. Circ Res 1992, 70:131-147.
16. Milliken M.C., Stray-Gundersen J., Peshock R.M., Katz J., Mitchell J.H. Left ventricular mass as determined by magnetic resonance imaging in male endurance athletes. Am J Cardiol 1988, 62:301-305.
17. Riley-Hagan M., Peshock R.M., Stray-Gundersen J., Katz J., Ryschon T.W., Mitchell J.H. Left ventricular dimensions and mass using magnetic resonance imaging in female endurance athletes. Am J Cardiol 1992, 69:1067-1074.
18. 2max: what do we know, and what do we still need to know?. J Physiol 2008, 586:25-34.
19. Levine B.D., Lane L.D., Buckey J.C., Friedman D.B., Blomqvist C.G. Left ventricular pressure-volume and Frank-Starling relations in endurance athletes. Implications for orthostatic tolerance and exercise performance. Circulation 1991, 84:1016-1023.
20. Levine B.D., Buckey J.C., Fritsch J.M., Yancy C.W., Watenpaugh D.E., Snell P.G., et al. Physical fitness and cardiovascular regulation: mechanisms of orthostatic intolerance. J Appl Physiol 1991, 70:112-122.
21. Stray-Gundersen J., Musch T.I., Haidet G.C., Swain D.P., Ordway G.A., Mitchell J.H. The effect of pericardiectomy on maximal oxygen consumption and maximal cardiac output in untrained dogs. Circ Res 1986, 58:523-530.
22. Hammond H.K., White F.C., Bhargava V., Shabetai R. Heart size and maximal cardiac output are limited by the pericardium. Am J Physiol 1992, 263:H1675-H1681.
23. Ferguson S., Gledhill N., Jamnik V.K., Wiebe C., Payne N. Cardiac performance in endurance-trained and moderately active young women. Med Sci Sports Exerc 2001, 33:1114-1119.
24. Warburton D.E., Gledhill N. Counterpoint: Stroke volume does not decline during exercise at maximal effort in healthy individuals. J Appl Physiol 2008, 104:276-278. [discussion 278-9].
25. Pelliccia A., Culasso F., Di Paolo F.M., Maron B.J. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999, 130:23-31.
26. Levine B.D., Zuckerman J.H., Pawelczyk J.A. Cardiac atrophy after bed-rest deconditioning: a nonneural mechanism for orthostatic intolerance. Circulation 1997, 96:517-525.
27. Thompson P.D. D. Bruce Dill Historical lecture. Historical concepts of the athlete's heart. Med Sci Sports Exerc 2004, 36:363-370.
28. Douglas P.S., O'Toole M.L., Hiller W.D., Hackney K., Reichek N. Cardiac fatigue after prolonged exercise. Circulation 1987, 76:1206-1213.
29. Shave R., George K.P., Atkinson G., Hart E., Middleton N., Whyte G., et al. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc 2007, 39:2099-2106.
30. Abergel E., Chatellier G., Hagege A.A., Oblak A., Linhart A., Ducardonnet A., et al. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol 2004, 44:144-149.
31. Breuckmann F., Mohlenkamp S., Nassenstein K., Lehmann N., Ladd S., Schmermund A., et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 2009, 251:50-57.
32. Maron B.J. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening. Br J Sports Med 2009, 43:649-656.
33. Pelliccia A., Kinoshita N., Pisicchio C., Quattrini F., Dipaolo F.M., Ciardo R., et al. Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes. J Am Coll Cardiol. 2010, 55:1619-1625.
34. Buttrick P.M., Scheuer J. Physiologic, biochemical, and coronary adaptation to exercise conditioning. Cardiol Clin 1987, 5:259-270.
35. Schaible T.F., Scheuer J. Cardiac adaptations to chronic exercise. Prog Cardiovasc Dis 1985, 27:297-324.
36. Loscalzo J., Kohane I., Barabasi A.L. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol 2007, 3:124.
37. Kuster D.W., Merkus D., van der Velden J., Verhoeven A.J., Duncker D.J. "Integrative Physiology 2.0": integration of systems biology into physiology and its application to cardiovascular homeostasis. J Physiol 2010, 589:1037-1045.
38. Penpargkul S., Scheuer J. The effect of physical training upon the mechanical and metabolic performance of the rat heart. J Clin Invest 1970, 49:1859-1868.
39. Malhotra A., Penpargkul S., Schaible T., Scheuer J. Contractile proteins and sarcoplasmic reticulum in physiologic cardiac hypertrophy. Am J Physiol 1981, 241:H263-H267.
40. Buttrick P.M., Kaplan M., Leinwand L.A., Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cardiol 1994, 26:61-67.
41. Malhotra A., Schaible T.F., Capasso J., Scheuer J. Correlation of myosin isoenzyme alterations with myocardial function in physiologic and pathologic hypertrophy. Eur Heart J 1984, 5(Suppl F):61-67.
42. Scheuer J., Malhotra A., Hirsch C., Capasso J., Schaible T.F. Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. J Clin Invest 1982, 70:1300-1305.
43. Schaible T.F., Ciambrone G.J., Capasso J.M., Scheuer J. Cardiac conditioning ameliorates cardiac dysfunction associated with renal hypertension in rats. J Clin Invest 1984, 73:1086-1094.
44. Chien K.R., Knowlton K.U., Zhu H., Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991, 5:3037-3046.
45. Galindo C.L., Skinner M.A., Errami M., Olson L.D., Watson D.A., Li J., et al. Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC Physiol 2009, 9:23.
46. Olivier B., Chan J.S., Pattij T., de Jong T.R., Oosting R.S., Veening J.G., et al. Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions?. Int J Impot Res 2006, 18(Suppl 1):S14-S23.
47. Giusti B., Marini M., Rossi L., Lapini I., Magi A., Capalbo A., et al. Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection. BMC Genomics 2009, 10:342.
48. Kong S.W., Bodyak N., Yue P., Liu Z., Brown J., Izumo S., et al. Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. Physiol Genomics 2005, 21:34-42.
49. Diffee G.M., Seversen E.A., Stein T.D., Johnson J.A. Microarray expression analysis of effects of exercise training: increase in atrial MLC-1 in rat ventricles. Am J Physiol Heart Circ Physiol 2003, 284:H830-H837.
50. Iemitsu M., Maeda S., Miyauchi T., Matsuda M., Tanaka H. Gene expression profiling of exercise-induced cardiac hypertrophy in rats. Acta Physiol Scand 2005, 185:259-270.
51. Strom C.C., Aplin M., Ploug T., Christoffersen T.E., Langfort J., Viese M., et al. Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy. FEBS J 2005, 272:2684-2695.
52. Ventura-Clapier R., Mettauer B., Bigard X. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res 2007, 73:10-18.
53. Stuewe S.R., Gwirtz P.A., Agarwal N., Mallet R.T. Exercise training enhances glycolytic and oxidative enzymes in canine ventricular myocardium. J Mol Cell Cardiol 2000, 32:903-913.
54. Murakami T., Shimomura Y., Fujitsuka N., Sugiyama S. Differential adaptation to endurance training between heart and gastrocnemius muscle mitochondria in rats. Biochem Mol Biol Int 1995, 36:285-290.
55. Weber K.T., Clark W.A., Janicki J.S., Shroff S.G. Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium. J Cardiovasc Pharmacol 1987, 10(Suppl 6):S37-S50.
56. Stanton L.W., Garrard L.J., Damm D., Garrick B.L., Lam A., Kapoun A.M., et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res 2000, 86:939-945.
57. Tan F.L., Moravec C.S., Li J., Apperson-Hansen C., McCarthy P.M., Young J.B., et al. The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA 2002, 99:11387-11392.
58. Nicholls D.G., Locke R.M. Thermogenic mechanisms in brown fat. Physiol Rev 1984, 64:1-64.
59. Lupu F., Terwilliger J.D., Lee K., Segre G.V., Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 2001, 229:141-162.
60. Dorn G.W., Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 2005, 115:527-537.
61. Rigor D.L., Bodyak N., Bae S., Choi J.H., Zhang L., Ter-Ovanesyan D., et al. Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function. Am J Physiol Heart Circ Physiol 2009, 296:H566-H572.
62. Condorelli G., Drusco A., Stassi G., Bellacosa A., Roncarati R., Iaccarino G., et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 2002, 99:12333-12338.
63. Matsui T., Li L., Wu J.C., Cook S.A., Nagoshi T., Picard M.H., et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 2002, 277:22896-22901.
64. Shioi T., McMullen J.R., Kang P.M., Douglas P.S., Obata T., Franke T.F., et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 2002, 22:2799-2809.
65. O'Neill B.T., Abel E.D. Akt1 in the cardiovascular system: friend or foe?. J Clin Invest 2005, 115:2059-2064.
66. Dorn G.W. The fuzzy logic of physiological cardiac hypertrophy. Hypertension 2007, 49:962-970.
67. Bostrom P., Mann N., Wu J., Quintero P.A., Plovie E.R., Panakova D., et al. C/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 2010, 143:1072-1083.
68. Baudino T.A., Carver W., Giles W., Borg T.K. Cardiac fibroblasts: friend or foe?. Am J Physiol Heart Circ Physiol 2006, 291:H1015-H1026.
69. Takeda N., Manabe I., Uchino Y., Eguchi K., Matsumoto S., Nishimura S., et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest. 2010, 120:254-265.
70. Sano M., Minamino T., Toko H., Miyauchi H., Orimo M., Qin Y., et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007, 446:444-448.
71. Giordano F.J., Gerber H.P., Williams S.P., VanBruggen N., Bunting S., Ruiz-Lozano P., et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 2001, 98:5780-5785.
72. Accornero F., van Berlo J.H., Benard M.J., Lorenz J.N., Carmeliet P., Molkentin J.D. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 2010, 109:272-280.